Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities

Abstract In recent decades, accumulating research on the interactions between microbiome homeostasis and host health has broadened new frontiers in delineating the molecular mechanisms of disease pathogenesis and developing novel therapeutic strategies. By transporting proteins, nucleic acids, lipid...

Full description

Bibliographic Details
Main Authors: Rongjin Luo, Yanmin Chang, Huaizhen Liang, Weifeng Zhang, Yu Song, Gaocai Li, Cao Yang
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:iMeta
Subjects:
Online Access:https://doi.org/10.1002/imt2.86
_version_ 1826945135245524992
author Rongjin Luo
Yanmin Chang
Huaizhen Liang
Weifeng Zhang
Yu Song
Gaocai Li
Cao Yang
author_facet Rongjin Luo
Yanmin Chang
Huaizhen Liang
Weifeng Zhang
Yu Song
Gaocai Li
Cao Yang
author_sort Rongjin Luo
collection DOAJ
description Abstract In recent decades, accumulating research on the interactions between microbiome homeostasis and host health has broadened new frontiers in delineating the molecular mechanisms of disease pathogenesis and developing novel therapeutic strategies. By transporting proteins, nucleic acids, lipids, and metabolites in their versatile bioactive molecules, extracellular vesicles (EVs), natural bioactive cell‐secreted nanoparticles, may be key mediators of microbiota–host communications. In addition to their positive and negative roles in diverse physiological and pathological processes, there is considerable evidence to implicate EVs secreted by bacteria (bacterial EVs [BEVs]) in the onset and progression of various diseases, including gastrointestinal, respiratory, dermatological, neurological, and musculoskeletal diseases, as well as in cancer. Moreover, an increasing number of studies have explored BEV‐based platforms to design novel biomedical diagnostic and therapeutic strategies. Hence, in this review, we highlight the recent advances in BEV biogenesis, composition, biofunctions, and their potential involvement in disease pathologies. Furthermore, we introduce the current and emerging clinical applications of BEVs in diagnostic analytics, vaccine design, and novel therapeutic development.
first_indexed 2024-03-13T10:52:05Z
format Article
id doaj.art-45b1e904449a4721a37c9a6a56318f1a
institution Directory Open Access Journal
issn 2770-596X
language English
last_indexed 2025-02-17T20:50:00Z
publishDate 2023-05-01
publisher Wiley
record_format Article
series iMeta
spelling doaj.art-45b1e904449a4721a37c9a6a56318f1a2024-12-09T07:45:59ZengWileyiMeta2770-596X2023-05-0122n/an/a10.1002/imt2.86Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunitiesRongjin Luo0Yanmin Chang1Huaizhen Liang2Weifeng Zhang3Yu Song4Gaocai Li5Cao Yang6Department of Orthopaedics, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Neurology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan ChinaAbstract In recent decades, accumulating research on the interactions between microbiome homeostasis and host health has broadened new frontiers in delineating the molecular mechanisms of disease pathogenesis and developing novel therapeutic strategies. By transporting proteins, nucleic acids, lipids, and metabolites in their versatile bioactive molecules, extracellular vesicles (EVs), natural bioactive cell‐secreted nanoparticles, may be key mediators of microbiota–host communications. In addition to their positive and negative roles in diverse physiological and pathological processes, there is considerable evidence to implicate EVs secreted by bacteria (bacterial EVs [BEVs]) in the onset and progression of various diseases, including gastrointestinal, respiratory, dermatological, neurological, and musculoskeletal diseases, as well as in cancer. Moreover, an increasing number of studies have explored BEV‐based platforms to design novel biomedical diagnostic and therapeutic strategies. Hence, in this review, we highlight the recent advances in BEV biogenesis, composition, biofunctions, and their potential involvement in disease pathologies. Furthermore, we introduce the current and emerging clinical applications of BEVs in diagnostic analytics, vaccine design, and novel therapeutic development.https://doi.org/10.1002/imt2.86biotherapyextracellular vesiclesmicrobiomemicrobiome–host interactionvaccine
spellingShingle Rongjin Luo
Yanmin Chang
Huaizhen Liang
Weifeng Zhang
Yu Song
Gaocai Li
Cao Yang
Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities
iMeta
biotherapy
extracellular vesicles
microbiome
microbiome–host interaction
vaccine
title Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities
title_full Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities
title_fullStr Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities
title_full_unstemmed Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities
title_short Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities
title_sort interactions between extracellular vesicles and microbiome in human diseases new therapeutic opportunities
topic biotherapy
extracellular vesicles
microbiome
microbiome–host interaction
vaccine
url https://doi.org/10.1002/imt2.86
work_keys_str_mv AT rongjinluo interactionsbetweenextracellularvesiclesandmicrobiomeinhumandiseasesnewtherapeuticopportunities
AT yanminchang interactionsbetweenextracellularvesiclesandmicrobiomeinhumandiseasesnewtherapeuticopportunities
AT huaizhenliang interactionsbetweenextracellularvesiclesandmicrobiomeinhumandiseasesnewtherapeuticopportunities
AT weifengzhang interactionsbetweenextracellularvesiclesandmicrobiomeinhumandiseasesnewtherapeuticopportunities
AT yusong interactionsbetweenextracellularvesiclesandmicrobiomeinhumandiseasesnewtherapeuticopportunities
AT gaocaili interactionsbetweenextracellularvesiclesandmicrobiomeinhumandiseasesnewtherapeuticopportunities
AT caoyang interactionsbetweenextracellularvesiclesandmicrobiomeinhumandiseasesnewtherapeuticopportunities